Diagnosis interval is the largest contributor to time to diagnosis and treatment for childhood cancer patients in India results of the InPOG-ACC-16-02 study
Saved in:
Main Authors: | Jyotsna Sharma (Author), Ramandeep Singh Arora (Author), A. Trehan (Author), S. Bakhshi (Author), M. Hazarika (Author), N. Verma (Author), P. Malhotra (Author), R. Tripathi (Author), I. Majhi (Author), J. Lowe (Author), J. William (Author), P. Bagai (Author), C. Guilmoto (Author), R.S. Arora (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Indian Pediatric Oncology Group (InPOG) - Collaborative research in India comes of age
by: Ramandeep Singh Arora, et al.
Published: (2016) -
InPOG-HL-15-01 - Challenges and lessons learnt in setting up the first collaborative multicentre prospective clinical trial in childhood cancer in India
by: Ramandeep Singh Arora, et al.
Published: (2020) -
First report on newly diagnosed Indian childhood Hodgkin lymphoma patients treated on a risk-stratified response-based collaborative protocol (InPOG-Hl-15-01)
by: Amita Mahajan, et al.
Published: (2017) -
Fate of children after the first relapse of acute lymphoblastic leukemia: InPOG-ALL-19-02 study
by: Pritam Singha Roy, et al.
Published: (2024) -
Outcomes of COVID-19 in children with cancer - Report from the Indian Pediatric Oncology Group (InPOG) COVID-19 registry in India
by: Revathi Raj, et al.
Published: (2022)